Security
Tandem Diabetes Care, Inc. Common Stock · TNDM
TNDMNASDAQCommon stockCurrentCIK 1438133Updated Oct 30, 2026
TNDM price & chart
Loading TradingView…
NASDAQ:TNDM on TradingView ↗About the company
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is headquartered in San Diego, California. For more information, visit tandemdiabetes.com.
In the news
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM News provided by THE ROSEN LAW FIRM, P. A. Jan 31, 2026, 13:31 ET Share this article Share to X Share this article Share to X NEW YORK , Jan. 31, 2026 /PRNewswire/ -- Why: Ros ↗
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM News provided by THE ROSEN LAW FIRM, P. A. Jan 26, 2026, 20:03 ET Share this article Share to X Share this article Share to X NEW YORK , Jan. 26, 2026 /PRNewswire/ -- Why: Ro ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 874,653,000Source | 957,730,000Source | 1,154,202,000Source | 875,736,000Source | 937,503,000Source | 1,153,394,000Source | 922,143,000Source | 941,045,000Source | 881,112,000Source | 967,658,000Source | 952,658,000Source | 1,052,785,000Source |
| Property, Plant and Equipment, NetUSD | 77,920,000Source | 81,064,000Source | 84,501,000Source | 77,513,000Source | 78,626,000Source | 83,250,000Source | 79,222,000Source | 77,530,000Source | 83,580,000Source | 78,150,000Source | 76,542,000Source | 68,552,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 91,947,000Source | 49,039,000Source | 62,818,000Source | 64,112,000Source | 47,697,000Source | 179,325,000Source | 53,574,000Source | 58,979,000Source | 90,634,000Source | 69,234,000Source | 58,868,000Source | 172,517,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 125,940,000Source | 107,188,000Source | 162,065,000Source | 128,443,000Source | 98,117,000Source | 140,672,000Source | 126,561,000Source | 92,965,000Source | 165,491,000Source | 114,585,000Source | 105,555,000Source | 114,717,000Source |
| Inventory, NetUSD | 137,284,000Source | 152,441,000Source | 135,106,000Source | 142,573,000Source | 161,661,000Source | 126,400,000Source | 141,165,000Source | 153,893,000Source | 128,769,000Source | 149,612,000Source | 157,937,000Source | 111,117,000Source |
| Assets, CurrentUSD | 616,944,000Source | 752,826,000Source | 804,639,000Source | 614,817,000Source | 733,388,000Source | 887,100,000Source | 663,435,000Source | 735,193,000Source | 618,143,000Source | 724,491,000Source | 747,989,000Source | 849,976,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 34,609,000Source | 19,892,000Source | 51,472,000Source | 28,440,000Source | 21,195,000Source | 49,772,000Source | 27,084,000Source | 20,525,000Source | 31,217,000Source | 21,965,000Source | 16,585,000Source | 7,241,000Source |
| Operating Lease, Right-of-Use AssetUSD | 98,364,000Source | 87,393,000Source | 100,185,000Source | 98,436,000Source | 88,243,000Source | 95,740,000Source | 101,017,000Source | 88,286,000Source | 96,172,000Source | 85,306,000Source | 87,791,000Source | 110,626,000Source |
| Other Assets, NoncurrentUSD | 16,521,000Source | 36,447,000Source | 32,606,000Source | 17,342,000Source | 37,246,000Source | 30,818,000Source | 7,464,000Source | 40,036,000Source | 22,866,000Source | 5,166,000Source | 40,336,000Source | 23,631,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 741,688,000Source | 720,020,000Source | 1,023,814,000Source | 742,453,000Source | 703,628,000Source | 1,020,991,000Source | 766,851,000Source | 697,981,000Source | 725,942,000Source | 704,560,000Source | 639,026,000Source | 612,838,000Source |
| Commitments and ContingenciesUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 68,000Source | 66,000Source | 70,000Source | 68,000Source | 65,000Source | 69,000Source | 67,000Source | 65,000Source | 68,000Source | 66,000Source | 66,000Source | 65,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,251,946,000Source | -1,048,580,000Source | -1,294,096,000Source | -1,230,781,000Source | -1,025,329,000Source | -1,272,928,000Source | -1,178,381,000Source | -994,515,000Source | -1,252,535,000Source | -1,047,825,000Source | -951,800,000Source | -729,189,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 5,168,000Source | 3,870,000Source | 6,403,000Source | 3,745,000Source | -1,253,000Source | 5,044,000Source | 75,000Source | -935,000Source | 5,593,000Source | -1,947,000Source | 1,369,000Source | -1,817,000Source |
| Stockholders' Equity Attributable to ParentUSD | 132,965,000Source | 237,710,000Source | 130,388,000Source | 133,283,000Source | 233,875,000Source | 132,403,000Source | 155,292,000Source | 243,064,000Source | 155,170,000Source | 263,098,000Source | 313,632,000Source | 439,947,000Source |
| Additional Paid in Capital, Common StockUSD | 1,379,675,000Source | 1,282,354,000Source | 1,418,011,000Source | 1,360,251,000Source | 1,260,392,000Source | 1,400,218,000Source | 1,333,531,000Source | 1,238,449,000Source | 1,402,044,000Source | 1,312,804,000Source | 1,263,997,000Source | 1,170,888,000Source |
| Liabilities and EquityUSD | 874,653,000Source | 957,730,000Source | 1,154,202,000Source | 875,736,000Source | 937,503,000Source | 1,153,394,000Source | 922,143,000Source | 941,045,000Source | 881,112,000Source | 967,658,000Source | 952,658,000Source | 1,052,785,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 252,542,000Source | 259,276,000Source | 253,005,000Source | 251,690,000Source | 240,610,000Source | 247,959,000Source | 288,175,000Source | 192,971,000Source | 242,724,000Source | 247,049,000Source | 195,258,000Source | 165,290,000Source |
| Operating Lease, Liability, CurrentUSD | 21,341,000Source | 18,033,000Source | 20,265,000Source | 19,888,000Source | 17,790,000Source | 20,109,000Source | 20,713,000Source | 17,320,000Source | 19,472,000Source | 18,208,000Source | 17,060,000Source | 13,121,000Source |
| Accounts Payable, CurrentUSD | 47,481,000Source | 48,754,000Source | 64,130,000Source | 55,838,000Source | 47,776,000Source | 59,860,000Source | 59,801,000Source | 48,143,000Source | 47,067,000Source | 44,730,000Source | 49,586,000Source | 55,730,000Source |
| Operating Lease, Liability, NoncurrentUSD | 118,353,000Source | 109,479,000Source | 116,411,000Source | 119,974,000Source | 111,392,000Source | 112,858,000Source | 123,048,000Source | 112,732,000Source | 114,967,000Source | 106,421,000Source | 113,572,000Source | 123,524,000Source |
| Other Liabilities, NoncurrentUSD | 52,380,000Source | 32,240,000Source | 44,045,000Source | 52,068,000Source | 32,498,000Source | 50,412,000Source | 37,065,000Source | 32,482,000Source | 49,741,000Source | 32,369,000Source | 31,830,000Source | 23,918,000Source |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | 125,940,000Source | 107,188,000Source | 162,065,000Source | 128,443,000Source | 98,117,000Source | 140,672,000Source | 126,561,000Source | 92,965,000Source | 165,491,000Source | 114,585,000Source | 105,555,000Source | 114,717,000Source |
| Accrued Liabilities, CurrentUSD | 12,539,000Source | 12,280,000Source | 25,539,000Source | 13,764,000Source | 13,225,000Source | 19,238,000Source | 13,689,000Source | 10,932,000Source | 21,012,000Source | 18,170,000Source | 12,726,000Source | 9,595,000Source |
| Long-term Debt, Current MaturitiesUSD | — | 40,605,000Source | — | — | 40,540,000Source | — | — | — | — | 40,670,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 309,590,000Source | 307,829,000Source | 602,577,000Source | 309,146,000Source | 307,392,000Source | 601,768,000Source | 308,705,000Source | — | 310,036,000Source | 308,266,000Source | — | — |
| Short-term InvestmentsUSD | 227,164,000Source | 424,266,000Source | 393,178,000Source | 251,249,000Source | 404,718,000Source | 390,931,000Source | 315,051,000Source | 408,831,000Source | 202,032,000Source | 369,095,000Source | 409,044,000Source | 444,384,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -20,393,000Source | -130,556,000Source | -204,710,000Source | -96,025,000Source | -222,611,000Source | -94,594,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 4,504,000Source | 4,311,000Source | 17,666,000Source | 16,607,000Source | 15,715,000Source | 14,330,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 15,660,000Source | 25,489,000Source | 92,381,000Source | 101,383,000Source | 88,076,000Source | 84,918,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -22,680,000Source | 10,843,000Source | 56,812,000Source | 20,795,000Source | -4,277,000Source | 7,830,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -1,927,000Source | -9,601,000Source | -24,816,000Source | -5,810,000Source | 46,053,000Source | 42,452,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 13,754,000Source | 6,637,000Source | 2,227,000Source | -2,392,000Source | -4,864,000Source | 24,493,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 11,054,000Source | -18,278,000Source | -9,721,000Source | 24,225,000Source | -31,810,000Source | 50,464,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -195,448,000Source | 9,186,000Source | 72,876,000Source | -23,482,000Source | -85,740,000Source | 33,168,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 6,268,000Source | 2,965,000Source | 19,948,000Source | 19,231,000Source | 26,804,000Source | 34,097,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | 0Source | 0Source | 30,000,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 274,161,000Source | -4,688,000Source | -43,367,000Source | 8,367,000Source | 4,113,000Source | 16,877,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | — | 0Source | 0Source | 183,000Source | -71,000Source | -675,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 88,691,000Source | -15,660,000Source | 21,400,000Source | 10,366,000Source | -113,649,000Source | 101,336,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 91,947,000Source | 49,039,000Source | 62,818,000Source | 64,112,000Source | 179,325,000Source | 53,574,000Source | 90,634,000Source | 69,234,000Source | 58,868,000Source | 172,517,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 5,049,000Source | 3,076,000Source | 7,565,000Source | 4,313,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 5,056,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -1,076,000Source | -1,880,000Source | 1,612,000Source | 1,256,000Source | -212,000Source | 827,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 21,142,000Source | 26,281,000Source | 15,741,000Source | 25,642,000Source | 15,660,000Source | 25,489,000Source | 92,381,000Source | 101,383,000Source | 88,077,000Source | 84,918,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | 576,000Source | 505,000Source | 1,860,000Source | 2,089,000Source | 2,204,000Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | — | — | 1,896,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 2,500,000Source | 1,900,000Source | 1,900,000Source | 2,000,000Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | 0Source | 0Source | — | 0Source | — | — | 2,000,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | -1,268,000Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | -2,724,000Source | 0Source | -5,641,000Source | -3,375,000Source | -3,865,000Source | -3,542,000Source | -14,194,000Source | -2,053,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | -3,978,000Source | 637,000Source | 510,000Source | -5,322,000Source | 516,000Source | 8,467,000Source | 4,438,000Source | 4,155,000Source | 2,357,000Source | 1,742,000Source |
| InterestExpenseNonoperatingUSD | — | — | 2,065,000Source | 1,865,000Source | 2,450,000Source | 1,905,000Source | 2,204,000Source | 1,862,000Source | 7,907,000Source | 7,415,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -21,165,000Source | -23,251,000Source | -21,168,000Source | -52,400,000Source | -20,393,000Source | -130,556,000Source | -204,710,000Source | -96,025,000Source | -222,611,000Source | -94,594,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -222,611,000Source | -94,594,000Source |
| Operating ExpensesUSD | — | — | 157,155,000Source | 150,746,000Source | 158,572,000Source | 177,665,000Source | 154,222,000Source | 239,285,000Source | 733,271,000Source | 588,701,000Source | 600,920,000Source | 505,834,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -2,280,000Source | 3,479,000Source | -6,866,000Source | -5,912,000Source | -2,443,000Source | -1,211,000Source | -13,015,000Source | 7,257,000Source | 12,976,000Source | -4,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | -6,730,000Source | 4,184,000Source | 17,469,000Source |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Operating Lease, Impairment Loss | — | — | — | — | — | — | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 249,253,000Source | 243,971,000Source | 254,560,000Source | 240,678,000Source | 247,221,000Source | 234,422,000Source | 1,014,736,000Source | 940,203,000Source | 747,718,000Source | 801,217,000Source |
| Cost of RevenueUSD | — | — | 114,961,000Source | 119,318,000Source | 109,780,000Source | 114,823,000Source | 110,433,000Source | 116,015,000Source | 468,722,000Source | 450,629,000Source | 380,028,000Source | 388,231,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 108,440,000Source | 99,639,000Source | 111,642,000Source | 109,596,000Source | 108,187,000Source | 113,853,000Source | 444,989,000Source | 389,824,000Source | 352,503,000Source | 335,681,000Source |
| Operating Income (Loss)USD | — | — | -22,863,000Source | -26,093,000Source | -13,792,000Source | -51,810,000Source | -17,434,000Source | -120,878,000Source | -187,257,000Source | -99,127,000Source | -233,230,000Source | -92,848,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -2,280,000Source | 3,479,000Source | -6,866,000Source | -5,912,000Source | -2,443,000Source | -1,211,000Source | -13,015,000Source | 7,257,000Source | 12,976,000Source | -4,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -25,143,000Source | -22,614,000Source | -20,658,000Source | -57,722,000Source | -19,877,000Source | -122,089,000Source | -200,272,000Source | -91,870,000Source | -220,254,000Source | -92,852,000Source |
| Income Tax Expense (Benefit)USD | — | — | -3,978,000Source | 637,000Source | 510,000Source | -5,322,000Source | 516,000Source | 8,467,000Source | 4,438,000Source | 4,155,000Source | 2,357,000Source | 1,742,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -21,165,000Source | -23,251,000Source | -21,168,000Source | -52,400,000Source | -20,393,000Source | -130,556,000Source | -204,710,000Source | -96,025,000Source | -222,611,000Source | -94,594,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.31Source | -0.35Source | -0.31Source | -0.78Source | -0.3Source | -1.97Source | -3.04Source | -1.47Source | -3.43Source | -1.47Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.31Source | -0.35Source | -0.31Source | -0.78Source | -0.3Source | -1.97Source | -3.04Source | -1.47Source | -3.43Source | -1.47Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 67,652,000Source | 65,538,000Source | 69,011,000Source | 67,050,000Source | 68,397,000Source | 66,404,000Source | 67,285,000Source | 65,451,000Source | 64,969,000Source | 64,146,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 67,652,000Source | 65,538,000Source | 69,011,000Source | 67,050,000Source | 68,397,000Source | 66,404,000Source | 67,285,000Source | 65,451,000Source | 64,969,000Source | 64,146,000Source |
| Interest Expense (non-operating)USD | — | — | 2,065,000Source | 1,865,000Source | 2,450,000Source | 1,905,000Source | 2,204,000Source | 1,862,000Source | 7,907,000Source | 7,415,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 2,500,000Source | 1,900,000Source | 1,900,000Source | 2,000,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 4,438,000Source | 4,155,000Source | 2,357,000Source | 1,742,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | — | — | 15,100,000Source | 14,700,000Source | 13,800,000Source | 12,300,000Source |
| Gross ProfitUSD | — | — | 134,292,000Source | 124,653,000Source | 144,780,000Source | 125,855,000Source | 136,788,000Source | 118,407,000Source | 546,014,000Source | 489,574,000Source | 367,690,000Source | 412,986,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -226,958,000Source | -78,156,000Source | -135,411,000Source | -94,033,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | -2,724,000Source | 0Source | -5,641,000Source | -3,375,000Source | -3,865,000Source | -3,542,000Source | -14,194,000Source | -2,053,000Source | — | — |
| Interest and Other IncomeUSD | — | — | — | 5,344,000Source | — | — | — | 4,193,000Source | — | 17,993,000Source | 22,858,000Source | 6,057,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -222,611,000Source | -94,594,000Source |
| Operating ExpensesUSD | — | — | 157,155,000Source | 150,746,000Source | 158,572,000Source | 177,665,000Source | 154,222,000Source | 239,285,000Source | 733,271,000Source | 588,701,000Source | 600,920,000Source | 505,834,000Source |
Filing attachments
ex991-q2earningsrelease2026.htm · 8-K · 2026-08-06
EX-99.1 2 ex991-q2earningsrelease2026.htm EX-99.1 Document Exhibit 99.1 Media Contact: 858-366-6900 media@tandemdiabetes.com Investor Contact: 858-366-6900 IR@tandemdiabetes.com FOR IMMEDIATE RELEASE Tandem Diabetes Care Announces Second Quarter 2026 Financial Results San Diego, August 6, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2026.…
Read attachment ↗ex991-q1earningsrelease2026.htm · 8-K · 2026-05-07
EX-99.1 2 ex991-q1earningsrelease2026.htm EX-99.1 Document Exhibit 99.1 Media Contact: 858-366-6900 media@tandemdiabetes.com Investor Contact: 858-366-6900 IR@tandemdiabetes.com FOR IMMEDIATE RELEASE Tandem Diabetes Care Announces First Quarter 2026 Financial Results San Diego, May 7, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed fi…
Read attachment ↗ef20066689_ex4-1.htm · 8-K · 2026-02-27
EX-4.1 2 ef20066689_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 TANDEM DIABETES CARE, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of February 27, 2026 0.00% Convertible Senior Notes due 2032 TABLE OF CONTENTS Page ARTICLE 1 Definitions Section 1.01. …
Read attachment ↗ef20066689_ex99-1.htm · 8-K · 2026-02-27
EX-99.1 4 ef20066689_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes SAN DIEGO, Calif., February 23, 2026 - Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of its Convertible Senior Notes due 2032 (the “notes”) in a private placement (the “…
Read attachment ↗ef20066689_ex99-2.htm · 8-K · 2026-02-27
EX-99.2 5 ef20066689_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032 SAN DIEGO, Calif., February 25, 2026 - Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the “notes”) in a private placement (the “offering”) to persons reasona…
Read attachment ↗ex991-q4earningsrelease2025.htm · 8-K · 2026-02-19
Exhibit 99.1 Media Contact: 858-366-6900 media@tandemdiabetes.com Investor Contact: 858-366-6900 IR@tandemdiabetes.com FOR IMMEDIATE RELEASE Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance San Diego, February 19, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provided …
Read attachment ↗